Intuitive Surgical, Inc. (ISRG), iRobot Corporation (IRBT): Robots for the Future

Page 1 of 2

The last time I wrote about Intuitive Surgical, Inc. (NASDAQ:ISRG), I devoted myself to dispelling false fears and shifting the focus to potential issues that could arise in an FDA probe. I now realize that there are a couple of issues that could further weigh on the company’s share price.

Probes can find too much

When a company is subject to regulatory oversight, the regulatory agency has the right to look at everything under its purview. The FDA started a regulatory probe into Intuitive Surgical, Inc. (NASDAQ:ISRG) due to an increased number of reports that something in Intuitive’s robotic da Vinci surgeries went wrong. The reporting standard is extremely broad and even the slightest hiccup is reported. In this case, many of the issues were the cables on the robotic arms breaking, but these can be fixed on site with no damage to the patient. However, as soon as the probe began, Intuitive informed its customers that there was a potential for electrical burns, though no actual proven cases, due to invisible cracks in the surgical scissors on the machines. The last time I wrote about Intuitive I gave very detailed numbers, and the whole point of the reporting system is that the FDA wants to spot potential problems as early as possible. This probe is not something I would consider out of the ordinary, but there is always a risk it will uncover something problematic.

Intuitive Surgical, Inc. (NASDAQ:ISRG)When the FDA looks at the da Vinci system, it doesn’t just look at narrow criteria. Even minor issues could require Intuitive Surgical, Inc. (NASDAQ:ISRG) to do a redesign. A problem could not happen often and when it does not be a big deal, but it could still warrant a redesign without requiring a halt to use. For the patient, this is for the best, but it could be a pain for the company and impact earnings as procedures decline. Any redesign needs to be approved by the FDA and, if the FDA puts a moratorium on new procedures, it could be an extended period of time that Intuitive is not making money off da Vinci procedures.

Wait on Intuitive Surgical, Inc. (NASDAQ:ISRG), because the risk of further losses is substantial. If the FDA asks for more information before coming to a decision, the stock will tumble on fear. Even if the long-term outlook is positive there are short-term gale-force headwinds. The stock recently shot up when Intuitive scored a legal victory. Precedent matters, and one case decided in its favor means that cases that rest on similar grounds should go the same way. However, there are still a lot of obstacles in Intuitive’s way. A positive result from the FDA would probably send the stock up high, but it will probably be too risky for most.

Cleanliness to wellness

iRobot Corporation (NASDAQ:IRBT) is entering the medical robots field with a telepresence device for doctors. This basically allows a doctor who is somewhere else to make visits to patients through the use of a robot that can navigate hospitals and has a large screen and webcam. It seems a bit unnerving, but I see it as a good innovation. The robot could help patients see doctors sooner, even if only electronically. The doctor can log into one machine and see one patient, and then log right into another machine while the first one travels to the next patient.

It will take some time for patients and doctors to get used to the idea. Patients will appreciate being able to see a doctor sooner, but the human touch will be diminished. Additionally, there are significant applications in security, considering that the machine is just a hunk of motion-detecting and scanning equipment. Equip it with the glowing red eyes and you have a great robotic security guard.

These robots are not consumer products, which means pricing pressures are far less than for, say, tablets. There really is no other competition to the telemedicine robot except physical people. Additionally, there will be recurring service income related to the robots, which will help bring more evenness to iRobot Corporation (NASDAQ:IRBT)’s revenue stream. It is still early, but in the consumer goods segment, once the sale is made that tends to be the end of it until replacement time rolls around.

Recent earnings were strong for iRobot Corporation (NASDAQ:IRBT), with the company beating estimates on revenue and earnings. The company closed the year with no long-term debt and cash of $138 million, which is good for a company this size. For now, home robots account for 90% of the company’s revenue, and I will be eager to see telepresence change that. The medical use is the first such use, but there are many other possibilities.

Page 1 of 2
blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

The 10 Most Overrated Movies Of All Time by Out-of-Touch Critics

Top 6 Least Expensive Cruise Destinations For 2015 that Will Take You to Paradise

10 States with Lowest Substance Abuse Rates in America

The 14 Most Watched TV Finales Ever

The 10 Best Selling Role Playing Games of All Time for PC

10 Most Influential Papers In Economics

Top 8 Biggest Charities in the US

10 Worst Celebrity Career Moves Ever

Top 10 Best Paid Tennis Stars in the World

10 Cities with High Demand for Nurses

6 of the Worst Greeting Card Messages Ever Crafted

6 Ways to Make Money in ArcheAge and Build Your Empire

10 Foods To Eat To Lower Cholesterol Levels

The 10 Most Hated Television Characters of All Time

The 30 Worst Halloween Costume Ideas Ever Brought to Horrible Life

10 Vocational Skills in Demand Today with Jobs Waiting to be Filled

10 Best Places to Visit in Central and South America

The 10 Greatest Empires in History Which Nearly Conquered the World

The 6 Cheapest Boarding Schools In America 2015

5 Clear Reasons LoL is Better than DotA, Continues to Rule MOBAs

The Only 9 Teams with a Chance to Win the Super Bowl

The 15 Most Common Phobias in America that Induce Fits of Panic

Top 6 Least Expensive Tourist Destinations in 2014

Jim Goetz, Peter Fenton, Jim Breyer: Top 6 Venture Investors for 2014

Top 15 Billionaires in 2014

5 Pitfalls To Avoid When Buying a Franchise

Top 20 Medical Schools in the US – 2014 Rankings

4 Business Strategies that Turned Jamie Oliver into the World’s Richest Chef

6 Qualities That Make You A Good Team Player

10 High Paying Seasonal Jobs in America this Holiday Season

The 10 Busiest Shipping Lanes in the World

5 Most Valuable Brands in China

The 10 States with Highest Substance Abuse Rates Crippling Their Populace

The Top 10 Things to Do Before You Die That Will Echo for Eternity

The 10 Best Selling Items on Etsy

Top 10 Things to Do in Tokyo, the Greatest City in the World

10 Mistakes on Social Media that Can Harm You and Will Probably Get You Canned

The 10 Best Cities to Find Jobs in 2014

The 10 Most Controversial Songs Of All Time to Hit (and get Banned from) the Airwaves

The 20 Biggest IPOs in US History

The 10 Best Places to Visit in Mexico that Are Beautiful and Safe

7 Bad Habits that Age You Beyond Your Years

The 40 Best Fortune Cookie Sayings That Will Leave You Bemused, Befuddled, or Beguiled

10 Foods to Eat Before a Workout to Make Every Drop of Sweat Count

The 5 Best Documentaries On Netflix You Must See

The Most Heartwarming and Inspirational Story Of This Halloween Season, It Will Make You Cry and Jump For Joy

10 Best Party Songs of All Time to Bring the House Down With

5 New World Order Conspiracy Theories that Will Strangle the World

The 10 Highest Rated Movies of 2014

The 10 Largest Container Shipping Companies in the World

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!